ClinicalTrials.Veeva

Menu

Comparison of Silicone-covered Metallic Ureteral Stent and Double-J Stent for Malignant Ureteral Obstruction

A

Asan Medical Center

Status and phase

Unknown
Phase 2

Conditions

Malignant Ureteral Obstruction

Treatments

Device: Double-J stent
Device: Silicone-covered metallic stent

Study type

Interventional

Funder types

Other

Identifiers

NCT01823575
JHS_URST

Details and patient eligibility

About

Malignant ureteral obstruction often necessitates chronic urinary diversion and is associated with high rates of failure with traditional double-J ureteral stents. To overcome drawbacks of the double-J stent, recently, metallic stents have been used to manage for palliative treatment in patients with ureteral obstruction associated with end stage malignant disease. The success rates of metallic stents have been reported to be high and the method proved to be useful in patients with malignant ureteral obstruction. In addition, covered metallic stents have many advantages compared with bare metallic stents, such as lower rate of tissue invasion and higher patency rate. However, there is little investigation about comparison of clinical efficacy between covered-metallic stents and double-J stents in malignant ureteral obstruction.

Therefore, investigators plan to perform a prospective randomized study to compare clinical efficacy of silicone-covered metallic ureteral stent and double-J ureteral stent in patients with malignant ureteral obstruction.

Enrollment

78 estimated patients

Sex

All

Ages

20 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age 20-80 years
  2. Malignant mid- to distal ureteral obstruction by abdominal or pelvic malignancy with overt hydronephrosis documented on CT scans
  3. Expected life expectancy more than three months

Exclusion criteria

  1. History of unilateral nephrectomy or bladder reconstruction
  2. History of kidney transplantation
  3. History of severe allergy to contrast media
  4. State of dialysis
  5. Performance status - 3 or 4 on ECOG scale

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

78 participants in 2 patient groups

Silicone-covered metallic ureteral stent
Experimental group
Description:
Deployment of a silicone-covered metallic ureteral stent for malignant ureteral obstruction and compare the results with placement of a double-J stent in terms of primary patency rate at 3 month follow-up (primary end point)
Treatment:
Device: Silicone-covered metallic stent
Double-J stent
Active Comparator group
Description:
Placement of a double-J stent for malignant ureteral obstruction and compare these results to deployment of a silicone-covered metallic stent in terms of primary patency rate at 3 month follow-up.
Treatment:
Device: Double-J stent

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems